http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-104652-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 1989-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb0f7311043e30c23a6efcad591321c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aafb8c8161b87f7d76fb2c3e3a9a819
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c8779ede961cad8511d74dcdb35f39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cb37714746c384793f1f88adce7718f
publicationDate 1994-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-104652-A
titleOfInvention A spiro compound
abstract A COMPOUND OF FORMULA I, HAVING ANTIBACTERIAL ACTIVITY AND A PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND OF FORMULA I: (FORMULA I ) WHEREIN A REPRESENTS AN INTEGER EQUAL TO 0 OR 1; B REPRESENTS AN INTEGER EQUAL TO 2 THROUGH 5, INCLUSIVE; C REPRESENTS AN INTEGER EQUALTO 0 OR 1; AND D REPRESENTS AN INTEGER EQUAL TO 0 THROUGH 2, INCLUSIVE; Z REPRESENTS CHR1, NR2, C=NOR3, AN OXYGEN ATOM OR A SULFUR ATOM, WHEREIN R1 REPRESENTS A HYDROGEN ATOM, AN AMINO GROUP, A MONOALKYLAMINO GROUP OF 1 TO 6 CARBON ATOMS, A DIALKYLAMINO GROUP CONTAINING 1 TO 6 CARBON ATOMS PER ALKYL, A HYDROXYL, AN ALKOXY GROUP OF 1 TO 6 TO CARBON ATOMS OR A HYDROXYALKYL GROUP OF 1 TO 6 CARBON ATOMS; R2 REPRESENTS A HYDROGEN ATOM, AN ALKYL GROUP OF 1 TO 6 CARBON ATOMS, A HYDROXYALKYL GROUP OF 1 TO 6 CARBON ATOMS, A HALOALKYL GROUP OF 1 TO 6 CARBON ATOMS, A FORMYL GROUP OR AN ALKYLCARBONYL GROUP OF 2 TO 7 CARBON ATOMS; AND R3 REPRESENTS A HYDROGEN ATOM OR AN ALKYL GROUP OF 1 TO 6 CARBON ATOMS; Q REPRESENTS A PARTIAL STRUCTURE OF FORMULA II: ( FORMULA II ) WHEREIN R4 REPRESENTS AN ALKYL GROUP OF 1 TO 6 CARBON ATOMS, AN ALKENYL GROUP OF 2 TO 6 CARBON ATOMS, A HALOALKYL GROUP OF 1 TO 6 CARBON ATOMS, A SUBSTITUTED CYCLOALKYL GROUP OF 3 TO 6 CARBON ATOMS, A SUBSTITUTED OR UNSUBSTITUTED ARYL GROUP, A SUBSTITUTED OR UNSUBSTITUTED HETEROARYL GROUP, AN ALKOXY GROUP OF 1 TO 6 CARBON ATOMS OR AN ALKYLAMINO GROUP OF 1 TO 6 CARBON ATOMS; R5 REPRESENTS A HYDROGEN ATOM OR AN ALKYL GROUP OF 1 TO 6 CARBON ATOMS; R6 REPRESENTS A HYDROGEN ATOM, A SUBSTITUTED OR UNSUBSTITUTED AMINO GROUP, A HYDROXYL GROUP, AN ALKOXY GROUP 1 TO 6 CARBON ATOMS OR A HALOGEN ATOM; A REPRESENTS A NITROGEN ATOM OR C-R7,WHEREIN R7 REPRESENTS A HYDROGEN ATOM,AN ALKYL GROUP OF 1 TO 6 CARBON ATOMS, A HALOGEN ATOM, AN ALKOXY GROUP OF 1 TO 6 CARBON ATOMS, A HALOALKYL GROUP OF 1 TO 6 CARBON ATOMS OR A CYANO GROUP ; R4 MAY,TAKEN TOGETHER WITH R5 AND/OR R7, FORM A SUBSTITUTED OR UNSUBSTITUTED RING WHICH CAN INCLUDE AN OXYGEN, NITROGEN OR SULFUR ATOM, WHEREIN THE SUBSTITUENT IS AN ALKYL GROUP OF 1 TO 6 CARBON ATOMS OR A HALOALKYL GROUP OF 1 TO 6 CARBON ATOMS; X REPRESENTS A HALOGEN ATOM; Y REPRESENTS A HYDROGEN ATOM, AN ALKYL GROUP OF 1 TO 6 CARBON ATOMS, AN ALKOXYALKYL GROUP OF 1 TO 6 CARBON ATOMS, A PHENYLALKYL GROUP CONTAINING 1 TO 6 CARBON ATOMS IN ITS ALKYL MOIETY, A DIHALOBORON GROUP, A PHENYL GROUP, AN ACETOXYMETHYL GROUP, A PIVALOYLOXYMETHYL GROUP, AN ETHOXYCARBONYLOXY GROUP, A CHOLINE GROUP, A DIMETHYLAMINOETHYL GROUP, A 5-INDANYL GROUP, A PHTALIDINYL GROUP, A 5-SUBSTITUTED-2-OXO-1, 3-DIOXAZOL-4-YLMETHYL GROUP OR A 3-ACETOXY-2-OXOBUTYL GROUP, OR A SALT THEREOF.
priorityDate 1988-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526621

Total number of triples: 40.